The cytochrome 11B2 aldosterone synthase gene rs1799998 single nucleotide polymorphism determines elevated aldosterone, higher blood pressure, and reduced glomerular filtration, especially in diabetic female patients

Abdel Ghafar MT. Aldosterone synthase gene (CYP11B2) polymorphisms and enhanced cardiovascular risk. In The recent topics in genetic polymorphisms (Eds. Çalişkan M, Erol O, Oz GC), IntechOpen Limited, London, 2019a.Search in Google Scholar

Abdel Ghafar MT. Association of aldosterone synthase CYP11B2 (−344C/T) gene polymorphism with essential hypertension and left ventricular hypertrophy in the Egyptian population. Clin Exp Hypertens 41, 779–786, 2019b.10.1080/10641963.2018.155767930561227Search in Google Scholar

Chai W, Hoedemaekers Y, van Schaik RH, van Fessem M, Garrelds IM, Saris JJ, Dooijes D, ten Cate FJ, Kofflard MM, Danser AH. Cardiac aldosterone in subjects with hypertrophic cardiomyopathy. J Renin Angiotensin Aldosterone Syst 7, 225–230, 2006.10.3317/jraas.2006.04217318792Search in Google Scholar

Chen JF, Jing J, Tan H, Song MB, Yu SY, Huang L. Lack of association of CYP11B2-344C/T polymorphism with essential hypertension: A meta-analysis. Int J Clin Exp Med 8, 9162–9167, 2015.Search in Google Scholar

Cheng X, Xu G. Association between aldosterone synthase CYP11B2 polymorphism and essential hypertension in Chinese: a meta-analysis. Kidney Blood Press Res 32, 128–140, 2009.10.1159/00021573819407459Search in Google Scholar

Connell JM, Fraser R, MacKenzie S, Davies E. Is altered adrenal steroid biosynthesis a key intermediate phenotype in hypertension? Hypertension 41, 993–999, 2003.10.1161/01.HYP.0000064344.00173.4412654713Search in Google Scholar

Connell JM, Davies E. The new biology of aldosterone. J Endocrinol 186, 1–20, 2005.10.1677/joe.1.0601716002531Search in Google Scholar

Dzhuryak V, Sydorchuk L, Sydorchuk A, Kamyshnyi O, Kshanovska A, Levytska S, Knut R, Sheremet M, Ivashchuk S, Petrynych O, Kazantseva T, Nikyfor L, Melnychuk L, Sokolenko A, Yarynych Y, Semianiv M, Repchuk Y, Voroniuk K, Sydorchuk R, Sokolenko L, Iftoda O, Kushnir O. The cytochrome 11B2 aldosterone synthase gene CYP11B2 (RS1799998) polymorphism associates with chronic kidney disease in hypertensive patients. Biointerface Research in Applied Chemistry 10, 5406–5411, 2020.Search in Google Scholar

Fernandes-Rosa FL, Williams TA, Riester A, Steichen O, Beuschlein F, Boulkroun S, Strom TM, Monticone S, Amar L, Meatchi T, Mantero F, Cicala MV, Quinkler M, Fallo F, Allolio B, Bernini G, Maccario M, Giacchetti G, Jeunemaitre X, Mulatero P, Reincke M, Zennaro MC. Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma. Hypertension 64, 354–361, 2014.10.1161/HYPERTENSIONAHA.114.0341924866132Search in Google Scholar

Freel EM, Connell JM. Mechanisms of hypertension: The expanding role of aldosterone. J Am Soc Nephrol 15, 1993–2001, 2004.10.1097/01.ASN.0000132473.50966.14128314215284285Search in Google Scholar

Ganapathipillai S, Laval G, Hoffmann IS, Castejon AM, Nicod J, Dick B, Frey FJ, Frey BM, Cubeddu LX, Ferrari P. CYP11B2-CYP11B1 haplotypes associated with decreased 11 beta-hydroxylase activity. J Clin Endocrinol Metab 90, 1220–1225, 2005.10.1210/jc.2004-103115507509Search in Google Scholar

Garg R, Adler GK. Aldosterone and the mineralocorticoid receptor: risk factors for cardiometabolic disorders. Curr Hypertens Rep 17, 52, 2015.10.1007/s11906-015-0567-826068659Search in Google Scholar

Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res 116, 991–1006, 2015.10.1161/CIRCRESAHA.116.305697436308725767285Search in Google Scholar

Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS; CKD-EPI Investigators. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367, 20–29, 2012.10.1056/NEJMoa1114248439802322762315Search in Google Scholar

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 150, 604–612, 2009.10.7326/0003-4819-150-9-200905050-00006276356419414839Search in Google Scholar

Leevin A, Stevens PE, Bilous RW, Coresh J, deFrancisco ALM, deJong P, Griffith KE, Hemmelgarn BR, Iseki K, Lamb EJ, et al. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Inter Suppl 3, 19–62, 2013.Search in Google Scholar

MacKenzie SM, Davies E, Alvarez-Madrazo S. Analysis of the aldosterone synthase (CYP11B2) and 11β-hydroxylase (CYP11B1) genes. Methods Mol Biol 1527, 139–150, 2017.10.1007/978-1-4939-6625-7_1128116713Search in Google Scholar

Nicod J, Bruhin D, Auer L, Vogt B, Frey FJ, Ferrari P. A biallelic gene polymorphism of CYP11B2 predicts increased aldosterone to renin ratio in selected hypertensive patients. J Clin Endocrinol Metab 88, 2495–2500, 2003.10.1210/jc.2002-02159812788845Search in Google Scholar

Schutten MT, Houben AJ, de Leeuw PW, Stehouwer CD. The link between adipose tissue renin-angiotensin-aldosterone system signaling and obesity-associated hypertension. Physiology (Bethesda) 32, 197–209, 2017.10.1152/physiol.00037.201628404736Search in Google Scholar

Sia SK, Chiou HL, Chen SC, Tsai CF, Yang SF, Ueng KC. Distribution and phenotypic expression of mineralocorticoid receptor and CYP11B2 T-344C polymorphisms in a Taiwanese hypertensive population. Mol Biol Rep 40, 3705–3711, 2013.10.1007/s11033-012-2446-623275203Search in Google Scholar

Stocco DM. StAR protein and the regulation of steroid hormone biosynthesis. Annu Rev Physiol 63, 193–213, 2001.10.1146/annurev.physiol.63.1.19311181954Search in Google Scholar

Sydorchuk LP, Sokolenko AA, Sydorchuk AR, Kryklyvets LG, Biryuk IG, Fliundra IG, Sokolenko MA. Insulin resistance in patients with arterial hypertension and abdominal obesity depending on ace and ppar-γ2 genes polymorphism: A new opinion concerning an old problem. New Armenian Medical Journal 9, 43–51, 2015a.Search in Google Scholar

Sydorchuk LP, Ursuliak YV. Genes allele status of angiotensinconverting enzyme (I/D) and endothelial nitric oxide synthase (894 G > T) in patients with acute coronary syndrome. Likarska sprava/Ministerstvo okhorony zdorovia Ukrainy (Ukraine) 5–6, 24–34, 2015b.Search in Google Scholar

Sydorchuk LP, Serdulets YI, Fediv OI, Havrysh LO, Teleki YM, Sydorchuk AR, Kshanovska AI, Turubarova-Leunova NA, Lekhai DO. The polymorphism of matrilin-3 (rs77245812) and interleukin-10 (rs1800872) genes in osteoarthritis patients with arterial hypertension, obesity and type 2 diabetes mellitus. Arch Balk Med Union 52, 422–429, 2017.10.24061/2413-0737.XXII.1.85.2018.18Search in Google Scholar

Tomaschitz A, Pilz S, Ritz E, Obermayer-Pietsch B, Pieber TR. Aldosterone and arterial hypertension. Nat Rev Endocrinol 6, 83–93, 2010.10.1038/nrendo.2009.26320027193Search in Google Scholar

Tsujita Y, Iwai N, Katsuya T, Higaki J, Ogihara T, Tamaki S, Kinoshita M, Mannami T, Ogata J, Baba S. Lack of association between genetic polymorphism of CYP11B2 and hypertension in Japanese: the Suita study. Hyper-tens Res 24, 105–109, 2001.10.1291/hypres.24.10511325068Search in Google Scholar

Tsybouleva N, Zhang L, Chen S, Patel R, Lutucuta S, Nemoto S, DeFreitas G, Entman M, Carabello BA, Roberts R, Marian AJ. Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy. Circulation 109, 1284–1291, 2004.10.1161/01.CIR.0000121426.43044.2B277953314993121Search in Google Scholar

Whaley-Connell A, Johnson MS, Sowers JR. Aldosterone: role in the cardiometabolic syndrome and resistant hyper-tension. Prog Cardiovasc Dis 52, 401–409, 2010.10.1016/j.pcad.2009.12.004284105720226958Search in Google Scholar

Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I, Authors/Task Force Members. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension [published correction appears in J Hypertens 37, 226, 2019]. J Hypertens 36, 1953–2041, 2018.Search in Google Scholar

Ye WJ, Zheng L, Wang ZH, Chen HH. [Meta analysis on the association of CYP11B2 gene polymorphism and essential hypertension in Chinese Han population.] Zhonghua Xin Xue Guan Bing Za Zhi 41, 795–799, 2013.Search in Google Scholar